Clinical Diagnostics

Clinical Diagnostics Market Research & Strategy Consulting

A complex balance of technological, clinical, regulatory, and commercial forces shape the clinical diagnostics industry. DeciBio provides comprehensive insight into those forces by assessing the technological and competitive landscape, evaluating new products and technologies, developing market forecasts, assessing strategic opportunities, and crafting overall business strategies.

Who We Work With

We provide clinical diagnostics market research and strategy consulting to diagnostic manufacturers, clinical labs, healthcare IT providers, and other stakeholders in the diagnostic industry.

Why Partner with Us

We combine our clinical diagnostics market research capabilities, and industry expertise, and leverage the knowledge of our comprehensive network of clinicians, laboratory directors, diagnostic KOLs, and regulatory and reimbursement experts to develop thorough, specific, and actionable solutions for our client.

Areas of expertise within the clinical diagnostic market include:

  • Molecular diagnostics
  • Companion diagnostics
  • Immunoassays
  • Clinical chemistry
  • Mass spectrometry
  • Point-of-care technologies
  • Regulatory strategy
  • Emerging diagnostic modalities (e.g., next-generation sequencing, multiplex technologies, others)
  • Biomarker strategy

Related Case Studies

Value proposition and go-to-market strategy development for a novel infectious disease diagnostic

Sizing and forecasting of the global market for multiplex syndromic panels for infectious disease testing and modelling the NPV of developing a new MDx platform

Sizing and forecasting of the immuno-oncology diagnostics market under multiple different growth, development, and reimbursement scenarios

Related Intelligence Products

Next Generation Sequencing (NGS) Market Assessment

Life Science Research Tools Market Assessment

Single Cell Genomics Market Assessment